{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T03:09:49Z","timestamp":1788491389690,"version":"build-2803163510"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T00:00:00Z","timestamp":1766448000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T00:00:00Z","timestamp":1769385600000},"content-version":"vor","delay-in-days":34,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R01HL167023"],"award-info":[{"award-number":["R01HL167023"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"DOI":"10.1186\/s13063-025-09385-6","type":"journal-article","created":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T01:45:28Z","timestamp":1766454328000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The Study in Outpatient Medicine using Nudges to Improve Sleep (SOMNUS): study protocol for an 18-month factorial, cluster-randomized trial to increase guideline-concordant treatment of insomnia in primary care"],"prefix":"10.1186","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6531-038X","authenticated-orcid":false,"given":"Jonathan N.","family":"Cloughesy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey A.","family":"Linder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tara K.","family":"Knight","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen D.","family":"Persell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark D.","family":"Sullivan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniella","family":"Meeker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiffany","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji Young","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily P.","family":"Stewart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig R.","family":"Fox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noah J.","family":"Goldstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ria Grace","family":"Sumitro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael V.","family":"Vitiello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy J.","family":"Mack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason N.","family":"Doctor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,23]]},"reference":[{"issue":"2","key":"9385_CR1","doi-asserted-by":"publisher","first-page":"263","DOI":"10.5664\/jcsm.8988","volume":"17","author":"JD Edinger","year":"2021","unstructured":"Edinger JD, Arnedt JT, Bertisch SM, Carney CE, Harrington JJ, Lichstein KL, et al. Behavioral and psychological treatments for chronic insomnia disorder in adults: an American Academy of Sleep Medicine systematic review, meta-analysis, and GRADE assessment. J Clin Sleep Med. 2021;17(2):263\u201398.","journal-title":"J Clin Sleep Med"},{"issue":"30","key":"9385_CR2","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.smrv.2015.11.004","volume":"1","author":"EM Wickwire","year":"2016","unstructured":"Wickwire EM, Shaya FT, Scharf SM. Health economics of insomnia treatments: the return on investment for a good night\u2019s sleep. Sleep Med Rev. 2016;1(30):72\u201382.","journal-title":"Sleep Med Rev"},{"issue":"3","key":"9385_CR3","doi-asserted-by":"publisher","first-page":"191","DOI":"10.7326\/M14-2841","volume":"163","author":"JM Trauer","year":"2015","unstructured":"Trauer JM, Qian MY, Doyle JS, Rajaratnam SMW, Cunnington D. Cognitive behavioral therapy for chronic insomnia. Ann Intern Med. 2015;163(3):191\u2013204.","journal-title":"Ann Intern Med"},{"issue":"3","key":"9385_CR4","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.smrv.2008.06.001","volume":"13","author":"D Riemann","year":"2009","unstructured":"Riemann D, Perlis ML. The treatments of chronic insomnia: a review of benzodiazepine receptor agonists and psychological and behavioral therapies. Sleep Med Rev. 2009;13(3):205\u201314.","journal-title":"Sleep Med Rev"},{"issue":"48","key":"9385_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.smrv.2019.08.002","volume":"1","author":"T van der Zweerde","year":"2019","unstructured":"van der Zweerde T, Bisdounis L, Kyle SD, Lancee J, van Straten A. Cognitive behavioral therapy for insomnia: a meta-analysis of long-term effects in controlled studies. Sleep Med Rev. 2019;1(48):101208.","journal-title":"Sleep Med Rev"},{"issue":"2015","key":"9385_CR6","first-page":"2302","volume":"13","author":"C Alessi","year":"2015","unstructured":"Alessi C, Vitiello MV. Insomnia (primary) in older people: non-drug treatments. BMJ Clin Evid. 2015;13(2015):2302.","journal-title":"BMJ Clin Evid"},{"issue":"1","key":"9385_CR7","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/1471-2296-13-40","volume":"13","author":"MD Mitchell","year":"2012","unstructured":"Mitchell MD, Gehrman P, Perlis M, Umscheid CA. Comparative effectiveness of cognitive behavioral therapy for insomnia: a systematic review. BMC Fam Pract. 2012;13(1):40.","journal-title":"BMC Fam Pract"},{"key":"9385_CR8","doi-asserted-by":"crossref","unstructured":"Qaseem A, Kansagara D, Forciea MA, Cooke M, Denberg TD, for the Clinical Guidelines Committee of the American College of Physicians. Management of chronic insomnia disorder in adults: a clinical practice guideline from the American College of Physicians. Ann Intern Med. 2016;165(2):125\u201333.","DOI":"10.7326\/M15-2175"},{"issue":"6","key":"9385_CR9","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1111\/jsr.12594","volume":"26","author":"D Riemann","year":"2017","unstructured":"Riemann D, Baglioni C, Bassetti C, Bjorvatn B, Dolenc Groselj L, Ellis JG, et al. European guideline for the diagnosis and treatment of insomnia. J Sleep Res. 2017;26(6):675\u2013700.","journal-title":"J Sleep Res"},{"issue":"8","key":"9385_CR10","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1177\/0269881119855343","volume":"33","author":"S Wilson","year":"2019","unstructured":"Wilson S, Anderson K, Baldwin D, Dijk DJ, Espie A, Espie C, et al. British Association for Psychopharmacology consensus statement on evidence-based treatment of insomnia, parasomnias and circadian rhythm disorders: an update. J Psychopharmacol. 2019;33(8):923\u201347.","journal-title":"J Psychopharmacol"},{"issue":"36","key":"9385_CR11","doi-asserted-by":"publisher","first-page":"S43","DOI":"10.1016\/j.sleep.2017.03.017","volume":"1","author":"M Ree","year":"2017","unstructured":"Ree M, Junge M, Cunnington D. Australasian Sleep Association position statement regarding the use of psychological\/behavioral treatments in the management of insomnia in adults. Sleep Med. 2017;1(36):S43-7.","journal-title":"Sleep Med"},{"key":"9385_CR12","doi-asserted-by":"crossref","unstructured":"Mysliwiec V, Martin JL, Ulmer CS, Chowdhuri S, Brock MS, Spevak C, et al. The management of chronic insomnia disorder and obstructive sleep apnea: synopsis of the 2019 U.S. Department of Veterans Affairs and U.S. Department of Defense Clinical Practice Guidelines. Ann Intern Med. 2020;172(5):325\u201336.","DOI":"10.7326\/M19-3575"},{"issue":"05","key":"9385_CR13","doi-asserted-by":"publisher","first-page":"487","DOI":"10.5664\/jcsm.27286","volume":"04","author":"S Schutte-Rodin","year":"2008","unstructured":"Schutte-Rodin S, Broch L, Buysse D, Dorsey C, Sateia M. Clinical guideline for the evaluation and management of chronic insomnia in adults. J Clin Sleep Med. 2008;04(05):487\u2013504.","journal-title":"J Clin Sleep Med"},{"issue":"6","key":"9385_CR14","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1007\/s11606-018-4390-1","volume":"33","author":"E Koffel","year":"2018","unstructured":"Koffel E, Bramoweth AD, Ulmer CS. Increasing access to and utilization of cognitive behavioral therapy for insomnia (CBT-I): a narrative review. J Gen Intern Med. 2018;33(6):955\u201362.","journal-title":"J Gen Intern Med"},{"key":"9385_CR15","unstructured":"FDA adds boxed warning for risk of serious injuries caused by sleepwalking with certain prescription insomnia medicines. U.S. Food & Drug Administration; 2019 Apr [cited 2024 Aug 26]. (Drug Safety Communications). Available from: https:\/\/www.fda.gov\/drugs\/drug-safety-and-availability\/fda-adds-boxed-warning-risk-serious-injuries-caused-sleepwalking-certain-prescription-insomnia"},{"key":"9385_CR16","doi-asserted-by":"crossref","unstructured":"Moore TJ, Mattison DR. Assessment of patterns of potentially unsafe use of zolpidem. JAMA Internal Medicine. 2018;178(9):1275\u20137.","DOI":"10.1001\/jamainternmed.2018.3031"},{"key":"9385_CR17","unstructured":"U.S. Food & Drug Administration. AMBIEN (zolpidem tartrate) prescribing information. 2022 [cited 2024 Aug 26]. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2022\/019908s40s044s047lbl.pdf"},{"issue":"3","key":"9385_CR18","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1056\/NEJMcp2305655","volume":"391","author":"CM Morin","year":"2024","unstructured":"Morin CM, Buysse DJ. Management of insomnia. N Engl J Med. 2024;391(3):247\u201358.","journal-title":"N Engl J Med"},{"issue":"6","key":"9385_CR19","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1002\/pds.5004","volume":"29","author":"K Harbourt","year":"2020","unstructured":"Harbourt K, Nevo ON, Zhang R, Chan V, Croteau D. Association of eszopiclone, zaleplon, or zolpidem with complex sleep behaviors resulting in serious injuries, including death. Pharmacoepidemiol Drug Saf. 2020;29(6):684\u201391.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"8","key":"9385_CR20","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1056\/NEJMp1307972","volume":"369","author":"RH Farkas","year":"2013","unstructured":"Farkas RH, Unger EF, Temple R. Zolpidem and driving impairment \u2014 identifying persons at risk. N Engl J Med. 2013;369(8):689\u201391.","journal-title":"N Engl J Med"},{"key":"9385_CR21","unstructured":"FDA approves new label changes and dosing for zolpidem products and a recommendation to avoid driving the day after using Ambien CR. U.S. Food & Drug Administration; 2013 May [cited 2024 Aug 26]. (Drug Safety Communications). Available from: https:\/\/www.fda.gov\/drugs\/drug-safety-and-availability\/fda-drug-safety-communication-fda-approves-new-label-changes-and-dosing-zolpidem-products-and"},{"issue":"4","key":"9385_CR22","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0174730","volume":"12","author":"K Donnelly","year":"2017","unstructured":"Donnelly K, Bracchi R, Hewitt J, Routledge PA, Carter B. Benzodiazepines, Z-drugs and the risk of hip fracture: a systematic review and meta-analysis. PLoS One. 2017;12(4):e0174730.","journal-title":"PLoS One"},{"issue":"4","key":"9385_CR23","doi-asserted-by":"publisher","first-page":"219","DOI":"10.3961\/jpmph.2012.45.4.219","volume":"45","author":"DY Kang","year":"2012","unstructured":"Kang DY, Park S, Rhee CW, Kim YJ, Choi NK, Lee J, et al. Zolpidem use and risk of fracture in elderly insomnia patients. J Prev Med Public Health. 2012;45(4):219\u201326.","journal-title":"J Prev Med Public Health"},{"issue":"5","key":"9385_CR24","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/j.mayocp.2014.01.021","volume":"89","author":"MM Lai","year":"2014","unstructured":"Lai MM, Lin CC, Lin CC, Liu CS, Li TC, Kao CH. Long-term use of zolpidem increases the risk of major injury: a population-based cohort study. Mayo Clin Proc. 2014;89(5):589\u201394.","journal-title":"Mayo Clin Proc"},{"issue":"7","key":"9385_CR25","doi-asserted-by":"publisher","first-page":"2052","DOI":"10.1111\/jgs.18372","volume":"71","author":"2023 American Geriatrics Society Beers Criteria\u00ae Update Expert Panel","year":"2023","unstructured":"2023 American Geriatrics Society Beers Criteria\u00ae Update Expert Panel. American Geriatrics Society 2023 updated AGS Beers Criteria\u00ae for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2023;71(7):2052\u201381.","journal-title":"J Am Geriatr Soc"},{"issue":"2","key":"9385_CR26","doi-asserted-by":"publisher","first-page":"343","DOI":"10.5665\/sleep.3410","volume":"37","author":"SM Bertisch","year":"2014","unstructured":"Bertisch SM, Herzig SJ, Winkelman JW, Buettner C. National use of prescription medications for insomnia: NHANES 1999\u20132010. Sleep. 2014;37(2):343\u20139.","journal-title":"Sleep"},{"key":"9385_CR27","first-page":"127","volume":"2005\u20132010","author":"Y Chong","year":"2013","unstructured":"Chong Y, Fryer CD, Gu Q. Prescription sleep aid use among adults: United States. 2013;2005\u20132010:127.","journal-title":"Prescription sleep aid use among adults: United States"},{"key":"9385_CR28","first-page":"384","volume-title":"Nudge: The Final Edition","author":"RH Thaler","year":"2021","unstructured":"Thaler RH, Sunstein CR. Nudge: The Final Edition. Yale University Press; 2021. p. 384."},{"issue":"6","key":"9385_CR29","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.5535","volume":"8","author":"A Mokhar","year":"2018","unstructured":"Mokhar A, Topp J, H\u00e4rter M, Schulz H, Kuhn S, Verthein U, et al. Patient-centered care interventions to reduce the inappropriate prescription and use of benzodiazepines and z-drugs: a systematic review. PeerJ. 2018;8(6):e5535.","journal-title":"PeerJ"},{"issue":"9","key":"9385_CR30","doi-asserted-by":"publisher","first-page":"1618","DOI":"10.1111\/add.14981","volume":"115","author":"T Lynch","year":"2020","unstructured":"Lynch T, Ryan C, Hughes CM, Presseau J, van Allen ZM, Bradley CP, et al. <article-title update=\"added\">Brief interventions targeting long\u2010term benzodiazepine and Z\u2010drug use in primary care: a systematic review and meta\u2010analysis. Addiction. 2020;115(9):1618\u201339.","journal-title":"Addiction"},{"issue":"8","key":"9385_CR31","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1007\/s11606-009-1013-x","volume":"24","author":"RJ Fortuna","year":"2009","unstructured":"Fortuna RJ, Zhang F, Ross-Degnan D, Campion FX, Finkelstein JA, Kotch JB, et al. Reducing the prescribing of heavily marketed medications: a randomized controlled trial. J Gen Intern Med. 2009;24(8):897.","journal-title":"J Gen Intern Med"},{"issue":"3","key":"9385_CR32","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1001\/jamainternmed.2023.7703","volume":"184","author":"JT Kullgren","year":"2024","unstructured":"Kullgren JT, Kim HM, Slowey M, Colbert J, Soyster B, Winston SA, et al. Using behavioral economics to reduce low-value care among older adults: a cluster randomized clinical trial. JAMA Intern Med. 2024;184(3):281\u201390.","journal-title":"JAMA Intern Med"},{"issue":"6","key":"9385_CR33","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1001\/jama.2016.0275","volume":"315","author":"D Meeker","year":"2016","unstructured":"Meeker D, Linder JA, Fox CR, Friedberg MW, Persell SD, Goldstein NJ, et al. Effect of behavioral interventions on inappropriate antibiotic prescribing among primary care practices: a randomized clinical trial. JAMA. 2016;315(6):562\u201370.","journal-title":"JAMA"},{"issue":"4","key":"9385_CR34","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.7481","volume":"4","author":"MA Bachhuber","year":"2021","unstructured":"Bachhuber MA, Nash D, Southern WN, Heo M, Berger M, Schepis M, et al. Effect of changing electronic health record opioid analgesic dispense quantity defaults on the quantity prescribed: a cluster randomized clinical trial. JAMA Netw Open. 2021;4(4):e217481.","journal-title":"JAMA Netw Open"},{"issue":"4","key":"9385_CR35","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1007\/s11606-017-4286-5","volume":"33","author":"MK Delgado","year":"2018","unstructured":"Delgado MK, Shofer FS, Patel MS, Halpern S, Edwards C, Meisel ZF, et al. Association between electronic medical record implementation of default opioid prescription quantities and prescribing behavior in two emergency departments. J Gen Intern Med. 2018;33(4):409\u201311.","journal-title":"J Gen Intern Med"},{"issue":"5","key":"9385_CR36","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1001\/jama.2025.4486","volume":"334","author":"AW Chan","year":"2025","unstructured":"Chan AW, Boutron I, Hopewell S, Moher D, Schulz KF, Collins GS, et al. SPIRIT 2025 statement: updated guideline for protocols of randomized trials. JAMA. 2025;334(5):435\u201343.","journal-title":"JAMA"},{"issue":"389","key":"9385_CR37","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2024-081660","volume":"28","author":"A Hr\u00f3bjartsson","year":"2025","unstructured":"Hr\u00f3bjartsson A, Boutron I, Hopewell S, Moher D, Schulz KF, Collins GS, et al. SPIRIT 2025 explanation and elaboration: updated guideline for protocols of randomised trials. BMJ. 2025;28(389):e081660.","journal-title":"BMJ"},{"issue":"15","key":"9385_CR38","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1056\/NEJMp1707991","volume":"377","author":"DA Asch","year":"2017","unstructured":"Asch DA, Ziolek TA, Mehta SJ. Misdirections in informed consent \u2014 impediments to health care innovation. N Engl J Med. 2017;377(15):1412\u20134.","journal-title":"N Engl J Med"},{"issue":"1","key":"9385_CR39","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/BF00055564","volume":"1","author":"W Samuelson","year":"1988","unstructured":"Samuelson W, Zeckhauser R. Status quo bias in decision making. J Risk Uncertainty. 1988;1(1):7\u201359.","journal-title":"J Risk Uncertainty"},{"issue":"4","key":"9385_CR40","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1037\/a0024354","volume":"17","author":"I Dinner","year":"2011","unstructured":"Dinner I, Johnson EJ, Goldstein DG, Liu K. Partitioning default effects: why people choose not to choose. J Exp Psychol Appl. 2011;17(4):332\u201341.","journal-title":"J Exp Psychol Appl"},{"issue":"5649","key":"9385_CR41","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1126\/science.1091721","volume":"302","author":"EJ Johnson","year":"2003","unstructured":"Johnson EJ, Goldstein D. Do defaults save lives? Science. 2003;302(5649):1338\u20139.","journal-title":"Science"},{"key":"9385_CR42","doi-asserted-by":"crossref","unstructured":"Tversky A, Kahneman D. Judgment under uncertainty: heuristics and biases. Science. 1974;185(4157):1124\u201331.","DOI":"10.1126\/science.185.4157.1124"},{"issue":"11","key":"9385_CR43","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1001\/jamasurg.2018.2083","volume":"153","author":"AS Chiu","year":"2018","unstructured":"Chiu AS, Jean RA, Hoag JR, Freedman-Weiss M, Healy JM, Pei KY. Association of lowering default pill counts in electronic medical record systems with postoperative opioid prescribing. JAMA Surg. 2018;153(11):1012\u20139.","journal-title":"JAMA Surg"},{"issue":"7","key":"9385_CR44","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2021-048801","volume":"11","author":"BS Last","year":"2021","unstructured":"Last BS, Buttenheim AM, Timon CE, Mitra N, Beidas RS. Systematic review of clinician-directed nudges in healthcare contexts. BMJ Open. 2021;11(7):e048801.","journal-title":"BMJ Open"},{"issue":"3","key":"9385_CR45","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.2437","volume":"5","author":"J Jia","year":"2022","unstructured":"Jia J, Linder JA. Default nudges in medicine\u2014designing the right choice. JAMA Netw Open. 2022;5(3):e222437.","journal-title":"JAMA Netw Open"},{"issue":"5","key":"9385_CR46","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1111\/j.1467-9280.2006.01721.x","volume":"17","author":"CRM McKenzie","year":"2006","unstructured":"McKenzie CRM, Liersch MJ, Finkelstein SR. Recommendations implicit in policy defaults. Psychol Sci. 2006;17(5):414\u201320.","journal-title":"Psychol Sci"},{"key":"9385_CR47","doi-asserted-by":"publisher","unstructured":"Baumeister RF, Hutton DG. Self-presentation theory: self-construction and audience pleasing. In: Theories of Group Behavior. Springer, New York, NY; 1987 [cited 2025 Jan 16]. p. 71\u201387. Available from: https:\/\/link.springer.com\/chapter\/https:\/\/doi.org\/10.1007\/978-1-4612-4634-3_4","DOI":"10.1007\/978-1-4612-4634-3_4"},{"issue":"6","key":"9385_CR48","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1037\/h0037450","volume":"59","author":"TH Jerdee","year":"1974","unstructured":"Jerdee TH, Rosen B. Effects of opportunity to communicate and visibility of individual decisions on behavior in the common interest. J Appl Psychol. 1974;59(6):712\u20136.","journal-title":"J Appl Psychol"},{"issue":"2","key":"9385_CR49","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1037\/0033-2909.125.2.255","volume":"125","author":"JS Lerner","year":"1999","unstructured":"Lerner JS, Tetlock PE. Accounting for the effects of accountability. Psychol Bull. 1999;125(2):255\u201375.","journal-title":"Psychol Bull"},{"issue":"6870","key":"9385_CR50","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1038\/415424a","volume":"415","author":"M Milinski","year":"2002","unstructured":"Milinski M, Semmann D, Krambeck HJ. Reputation helps solve the \u2018tragedy of the commons.\u2019 Nature. 2002;415(6870):424\u20136.","journal-title":"Nature"},{"key":"9385_CR51","unstructured":"Sparks A, Cohen A, Albright B, Barkett P, Caldeiro R, Chau J, et al. Benzodiazepine and Z-drug safety guideline. Kaiser Foundation Health Plan of Washington; 2022;1\u201326.\u00a0https:\/\/wa-provider.kaiserpermanente.org\/provider-manual\/patient-care\/clinical-guidelines."},{"key":"9385_CR52","doi-asserted-by":"crossref","unstructured":"Hong SM, Page S. A Psychological Reactance Scale: development, factor structure and reliability. Psychol Rep. 1989;64(3_suppl):1323\u20136.","DOI":"10.2466\/pr0.1989.64.3c.1323"},{"key":"9385_CR53","doi-asserted-by":"crossref","unstructured":"Bri\u00f1ol P, Rucker DD, Tormala ZL, Petty RE. Individual differences in resistance to persuasion: the role of beliefs and meta-beliefs. In: Resistance and persuasion. Mahwah, NJ, US: Lawrence Erlbaum Associates Publishers; 2004;83\u2013104.","DOI":"10.1037\/t88807-000"},{"issue":"1","key":"9385_CR54","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1037\/0022-3514.44.1.113","volume":"44","author":"MH Davis","year":"1983","unstructured":"Davis MH. Measuring individual differences in empathy: evidence for a multidimensional approach. J Pers Soc Psychol. 1983;44(1):113.","journal-title":"J Pers Soc Psychol"},{"issue":"8","key":"9385_CR55","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1007\/s00228-023-03515-2","volume":"79","author":"K Isomura","year":"2023","unstructured":"Isomura K, Wang X, Chang Z, Hellner C, Hasselstr\u00f6m J, Ekheden I, et al. Factors associated with long-term benzodiazepine and Z-drug use across the lifespan and 5-year temporal trajectories among incident users: a Swedish nationwide register-based study. Eur J Clin Pharmacol. 2023;79(8):1091\u2013105.","journal-title":"Eur J Clin Pharmacol"},{"issue":"8","key":"9385_CR56","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1016\/j.eurpsy.2015.09.003","volume":"30","author":"TaT Kurko","year":"2015","unstructured":"Kurko TaT, Saastamoinen LK, T\u00e4hk\u00e4p\u00e4\u00e4 S, Tuulio-Henriksson A, Taiminen T, Tiihonen J, et al. Long-term use of benzodiazepines: definitions, prevalence and usage patterns \u2013 a systematic review of register-based studies. Eur Psychiatry. 2015;30(8):1037\u201347.","journal-title":"Eur Psychiatry"},{"issue":"11","key":"9385_CR57","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2020-046916","volume":"11","author":"J Brandt","year":"2021","unstructured":"Brandt J, Janzen D, Alessi-Severini S, Singer A, Chateau D, Enns M, et al. Risk of long-term benzodiazepine and Z-drug use following the first prescription among community-dwelling adults with anxiety\/mood and sleep disorders: a retrospective cohort study. BMJ Open. 2021;11(11):e046916.","journal-title":"BMJ Open"},{"issue":"31","key":"9385_CR58","first-page":"58","volume":"14","author":"T Ara\u00fajo","year":"2016","unstructured":"Ara\u00fajo T, Jarrin DC, Leanza Y, Valli\u00e8res A, Morin CM. Qualitative studies of insomnia: current state of knowledge in the field. Sleep Med Rev. 2016;14(31):58.","journal-title":"Sleep Med Rev"},{"issue":"64","key":"9385_CR59","doi-asserted-by":"publisher","DOI":"10.1016\/j.smrv.2022.101648","volume":"1","author":"Y Gao","year":"2022","unstructured":"Gao Y, Ge L, Liu M, Niu M, Chen Y, Sun Y, et al. Comparative efficacy and acceptability of cognitive behavioral therapy delivery formats for insomnia in adults: a systematic review and network meta-analysis. Sleep Med Rev. 2022;1(64):101648.","journal-title":"Sleep Med Rev"},{"issue":"75","key":"9385_CR60","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.sleep.2020.08.020","volume":"1","author":"HL Soh","year":"2020","unstructured":"Soh HL, Ho RC, Ho CS, Tam WW. Efficacy of digital cognitive behavioural therapy for insomnia: a meta-analysis of randomised controlled trials. Sleep Med. 2020;1(75):315\u201325.","journal-title":"Sleep Med"}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13063-025-09385-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-025-09385-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-025-09385-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T16:03:51Z","timestamp":1769443431000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13063-025-09385-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,23]]},"references-count":60,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["9385"],"URL":"https:\/\/doi.org\/10.1186\/s13063-025-09385-6","relation":{},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,23]]},"assertion":[{"value":"12 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The trial protocol was reviewed and approved by the University of Southern California Institutional Review Board (UP-23-00317). A waiver of informed consent was obtained for trial clinician enrollment and review of EHR data because the IRB deemed the research involves no more than minimal risk, could not practicably be carried out without the waiver, and will not adversely affect the rights and welfare of subjects, thereby fulfilling the criteria for a waiver in the USA. Informed consent was required for the clinician survey and education module.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate {30}"}},{"value":"Not applicable because no information relating to any individual person will be published.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"S. D. P. receives unrelated research support from Omron Healthcare Co. Ltd.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests {7b}"}}],"article-number":"85"}}